Annual Drug Patent Expirations for CIPRODEX
Ciprodex is a drug marketed by Novartis and is included in one NDA. It is available from three suppliers. There are four patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for CIPRODEX.
This drug has eighteen patent family members in sixteen countries.
The generic ingredient in CIPRODEX is ciprofloxacin; dexamethasone. Three suppliers are listed for this compound. Additional details are available on the ciprofloxacin; dexamethasone profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
